; and (2) meet the needs of high-risk and high-exposure patients. 5. Increasing influenza vaccine, therapeutics, and testing access and coverage across all populations (a) Annual report on public communication strategy The Director of the Centers for Disease Control and Prevention shall submit an annual report to the Congress on the public communication strategy of the Centers to increase public confidence in the safety and effectiveness of vaccines. (b) Sense of Congress It is the sense of Congress that the National Institutes of Health, the Director of the Centers for Disease Control and Prevention, the Secretary of Defense, the Secretary of Veterans Affairs, the Administrator of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs should support research using large data sets from multiple sources of health data to further support and evaluate vaccine safety and effectiveness over multiple influenza seasons. (c) Addressing misinformation and disinformation (1) In general The Secretary of Health and Human Services shall create partnerships to address misinformation and disinformation with respect to influenza vaccines. (2) Requirements The partnerships under paragraph (1) shall— (A) build on lessons learned from COVID–19; and (B) allow for dissemination of best practices and lessons learned between partnering organizations. (3) Members The members of the partnerships under paragraph (1) shall include representatives of organizations with experience working with vulnerable populations, including— (A) individuals with chronic health conditions; (B) older Americans; (C) parents of young children; (D) pregnant people; (E) Tribal communities; and (F) racial and ethnic minorities. (4) Conferring with partnering organizations The Secretary of Health and Human Services shall confer with organizations represented in partnerships under paragraph (1)— (A) in advance of each seasonal influenza season, on messaging and communications